YASUNOBU YAMASHITA

Dr. YASUNOBU YAMASHITA

Wakayama Medical University, Wakayama, Japan
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in Journal of Ultrasound in Medicine
Verified
Journal Article
Closed access
PDF file
YASUNOBU YAMASHITAYASUNOBU YAMASHITA
YASUNOBU YAMASHITA
KUKazuki Ueda
Kazuki Ueda
MIMasahiro Itonaga
Masahiro Itonaga
TYTakeichi Yoshida
Takeichi Yoshida
HMHiroki Maeda
Hiroki Maeda
JKJun Kato
Jun Kato

3 February 2022 in Digestive Endoscopy
Verified
Journal Article
Closed access
PDF file
YASUNOBU YAMASHITAYASUNOBU YAMASHITA
YASUNOBU YAMASHITA
ATAyaka Tachikawa
Ayaka Tachikawa
TSToshio Shimokawa
Toshio Shimokawa
HYHirofumi Yamazaki
Hirofumi Yamazaki
MIMasahiro Itonaga
Masahiro Itonaga
MKMasayuki Kitano
Masayuki Kitano

7 January 2021 in Digestive Endoscopy
Verified
Journal Article
Open access
PDF file
Takashi TamuraTakashi Tamura
Takashi Tamura
MIMasahiro Itonaga
Masahiro Itonaga
RAReiko Ashida
Reiko Ashida
YASUNOBU YAMASHITAYASUNOBU YAMASHITA
YASUNOBU YAMASHITA
KHKeiichi Hatamaru
Keiichi Hatamaru
MKMasayuki Kitano
Masayuki Kitano
Objectives: This single‐center comparative randomized superiority study compared biliary stenting using fully covered self‐expandable metal stents (FCSEMS) and biliary stenting using plastic stents (PS) in preoperative biliary drainage of patients with borderline resectable pancreatic cancer (BRPC) who are planned to undergo a single regimen of neo‐adjuvant chemotherapy (NAC).Methods: Twenty‐two patients with BRPC who required preoperative biliary drainage before NAC (Gemcitabine plus Nab‐paclitaxel) were randomly assigned 1:1 to the FCSEMS or PS group. The primary endpoint was the rate of stent dysfunction until surgery or tumor progression. Secondary endpoints were stent patency, number of re‐interventions, adverse events of endoscopic retrograde biliary drainage (EBD), operation time, volume of intraoperative bleeding, postoperative hospitalization, postoperative adverse events and medical costs.Results: Eleven patients in each of the groups reached the primary endpoint. The FCSEMS group showed a significantly lower rate of stent dysfunction (18.2% vs. 72.8%, P = 0.015), longer stent patency (P = 0.02), and lower number of re‐interventions for stent dysfunction (0.27 ± 0.65 vs. 1.27 ± 1.1, P = 0.001) than the PS group. The adverse events of EBD, operation time, volume of intraoperative bleeding, postoperative hospitalization, postoperative adverse events and medical costs did not significantly differ between the two groups.Conclusions: In patients with BRPC for preoperative biliary drainage, stent dysfunction occurred less frequently with FCSEMSs than with PSs. In addition, FCSEMS and PS provided similar preoperative management of BRPC in terms of the safety of surgery and medical costs. (UMIN ID000030473).

15 September 2020 in Gut and Liver
Verified
Journal Article
Open access
PDF file
YASUNOBU YAMASHITAYASUNOBU YAMASHITA
YASUNOBU YAMASHITA
KTKensuke Tanioka
Kensuke Tanioka
YKYuki Kawaji
Yuki Kawaji
Takashi TamuraTakashi Tamura
Takashi Tamura
JNJunya Nuta
Junya Nuta
MKMasayuki Kitano
Masayuki Kitano
Yasunobu Yamashita, Kensuke Tanioka, Yuki Kawaji, Takashi Tamura, Junya Nuta, Keiichi Hatamaru, Masahiro Itonaga, Takeichi Yoshida, Yoshiyuki Ida, Takao Maekita, Mikitaka Iguchi, and Masayuki Kitano. Gut and Liver 1999;0:. https://doi.org/10.5009/gnl19170

18 May 2015 in BioMed Research International
Verified
Journal Article
Open access
PDF file
YASUNOBU YAMASHITAYASUNOBU YAMASHITA
YASUNOBU YAMASHITA
JKJun Kato
Jun Kato
KUKazuki Ueda
Kazuki Ueda
YNYasushi Nakamura
Yasushi Nakamura
YKYuki Kawaji
Yuki Kawaji
MIMasao Ichinose
Masao Ichinose
Objectives. To investigate the usefulness of contrast-enhanced endoscopic ultrasonography (CE-EUS) for histological differentiation of pancreatic tumors.Methods. CE-EUS was performed for consecutive patients having a pancreatic solid lesion, and tumors were classified into three vascular patterns (hypervascular, isovascular, and hypovascular) at two time phases (early-phase and late-phase). Correlation between vascular patterns and histopathology of resected pancreatic cancer (PC) tissues was ascertained.Results. The final diagnoses of 147 examined tumors were PC(n=109), inflammatory mass(n=11), autoimmune pancreatitis(n=9), neuroendocrine tumor(n=8), and others(n=10). In late-phase images, 104 of 109 PCs had the hypovascular pattern, for a diagnostic sensitivity and specificity of 94% and 71%, respectively. Of 28 resected PCs, 10 had isovascular, and 18 hypovascular, patterns on the early-phase image. Early-phase isovascular PCs were more likely to be differentiated than were early-phase hypovascular PCs (6 well and 4 moderately differentiated versus 3 well, 14 moderately, and 1 poorly differentiated,P=0.028). Immunostaining revealed that hypovascular areas of early-phase images reflected heterogeneous tumor cells with fibrous tissue, necrosis, and few vessels.Conclusion. CE-EUS could be useful for distinguishing PC from other solid pancreatic lesions and for histological differentiation of PCs.

13 July 2023 in DEN Open
Verified
Journal Article
Open access
HYHirofumi Yamazaki
Hirofumi Yamazaki
YASUNOBU YAMASHITAYASUNOBU YAMASHITA
YASUNOBU YAMASHITA
TSToshio Shimokawa
Toshio Shimokawa
KMKosuke Minaga
Kosuke Minaga
TOTakeshi Ogura
Takeshi Ogura
MKMasayuki Kitano
Masayuki Kitano
Objectives: Endoscopic ultrasound (EUS)‐guided biliary drainage encompasses techniques such as EUS‐guided hepaticogastrostomy (EUS‐HGS) and EUS‐guided choledochoduodenostomy (EUS‐CDS). This meta‐analysis compared the efficacy of EUS‐CDS with that of EUS‐HGS for the treatment of biliary obstruction.Methods: A systematic meta‐analysis of all relevant articles listed was performed by searching the Cochrane Library, PubMed, and Google Scholar databases. We used random effects or fixed effects models to compare success rates, adverse events, procedure times, and time to recurrent biliary obstruction after EUS‐CDS and EUS‐HGS.Results: This meta‐analysis included 18 eligible studies. There was no significant difference between EUS‐CDS and EUS‐HGS with respect to technical success rate (odds ratio [OR] 1.04; 95% confidence interval [CI] 0.62–1.73) and clinical success rate (OR 0.66; 95% CI 0.43–1.04), or with respect to total procedure‐related adverse events (OR 1.39; 95% CI 1.00–1.93). Subgroup analysis of adverse events revealed that the rate of recurrent biliary obstruction (RBO) was significantly higher for EUS‐HGS (OR 2.95; 95% CI 1.54–5.64). There was no significant difference between the two methods with respect to time to recurrent biliary obstruction (mean difference –11.93 days; 95% CI –47.77–23.91). However, the procedure time was longer for EUS‐HGS (mean difference, 3.21 min; 95% CI 1.24–5.19).Conclusion: EUS‐CDS and EUS‐HGS are comparable in terms of technical success, clinical success, and rate of adverse events; however, EUS‐CDS is superior with respect to procedure time and preventing RBO.